Benefit of surgical resection of distant metastasis in soft tissue sarcoma: a systematic review
Authors:
- 6 April 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 51 (7) , 1088-1093
Abstract
Objective: The aim of this systematic review was to evaluate the efficacy of metastasectomy for patients with advanced soft tissue sarcoma and to develop a recommendation outlining clinical guidelines for soft tissue sarcoma. Methods: We searched the pertinent literature from January 1985 to December 2017. Two reviewers evaluated and screened the literature independently for eligibility and extracted data. We evaluated the quality of body of evidence and made a recommendation according to the Grading of Recommendations Development and Evaluation methodology. Results: Among 244 identified studies, only 10 were finally included in this review and no randomized controlled trial reports were present. The median survival period after metastasectomy ranged from 9.6 to 39.6 months, and the 5-year survival rate ranged from 8 to 52%. The complication rate ranged from 7.3 to 25%, and the perioperative mortality rate was 0–1%. The guidelines committee proposed ‘Metastasectomy can be offered for malignant soft tissue tumours with distant metastases’. This recommendation gained 100% consensus among the members of the guidelines group. Conclusions: Although the level of evidence is very low, many retrospective studies support a clinical advantage for metastasectomy, and surgical indications should be carefully considered for patients with metastasis from soft tissue sarcoma. Metastasectomy is an option for patients with metastasis and should be done only if it can be performed safely and if potential advantages outweigh disadvantages.Keywords
Funding Information
- Japanese Orthopaedic Association
This publication has 22 references indexed in Scilit:
- Novel Insights of Oligometastases and Oligo-Recurrence and Review of the LiteraturePulmonary Medicine, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Soft tissue sarcoma across the age spectrum: A population‐based study from the surveillance epidemiology and end results databasePediatric Blood & Cancer, 2011
- Liver resection for metastatic soft tissue sarcoma: An analysis of prognostic factorsEuropean Journal of Surgical Oncology, 2011
- Oligometastases and Oligo-recurrence: The New Era of Cancer TherapyJapanese Journal of Clinical Oncology, 2010
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009
- Pulmonary Resection for Metastatic Malignant Fibrous Histiocytoma: An Analysis of Prognostic FactorsThe Annals of Thoracic Surgery, 2005
- Grading quality of evidence and strength of recommendationsBMJ, 2004
- Soft tissue sarcoma brain metastasesCancer, 2002
- Lung metastasectomy in patients with soft tissue sarcomaBritish Journal of Radiology, 1994